Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Pete Bantock, Julie Khani

Premium

Accelerate Diagnostics this week appointed Pete Bantock as its new chief commercial officer. Recently, Bantock was senior VP and general manager of Ventana Medical Systems, in charge of commercial operations in North America.

Before that, Bantock was general manager of Ventana's Spring Bioscience division, and held various positions at the company, including director of marketing and head of corporate accounts. Prior to working at Ventana, Bantock was manager of South African commercial operations within Abbott Labs' diagnostics division.


The American Clinical Laboratory Association has named Julie Khani to be its senior VP, a new position at the organization. Khani will oversee advocacy and policy operations, and will run a team of three vice presidents.

She recently was vice president of public policy at the National Association of Chain Drug Stores, and before that she was the association's director of federal and legislative affairs. Prior to her 11 years at NACDS, Khani was a legislative manager at Ford Motor Company.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.